🔗 Permalink

Inventor profile of:

Steven G. Wright

City:

Madeira, Ohio

Country:

United States

Published Applications:

Last publication date:

2024-07-25

Top Assignees for applications by Steven G. Wright

The entities that hold a legal rights for patent applications filed by inventor Wright Steven G.:

ALKERMES PHARMA IRELAND LIMITED 17 Dublin, Ireland
Alkermes, Inc. 15 Cambridge, MA United States
Alkermes Controlled Therapeutics Inc. II 4 Cambridge, MA United States
Alkermes, Inc. 4 Waltham, MA United States
Amylin Pharmaceuticals, Inc. 3 San Diego, CA United States
Alkernnes Pharma Ireland Limited 1 Dublin, Ireland
AMYLIN PHARMACEUTICALS, INC. 1 SAN DIEGO CA, Canada
Amylin Pharmaceuticals, LLC 1 San Diego, CA United States
ALKEMES CONTROLLED THERAPEUTICS, 1 CAMBRIGE MA, Morocco

Recent patent applications by Wright Steven G.

Steven G. Wright from Madeira, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-07-25

US20240245676A1

Human necessities

CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA

#2 | 2021-07-08

US20210205302A1

Human necessities

Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia

#3 | 2020-12-17

US20200390891A1

Human necessities

POLYMER-BASED SUSTAINED RELEASE DEVICE

#4 | 2020-04-09

US20200108063A1

Human necessities

Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia

#5 | 2019-06-06

US20190167664A1

Human necessities

Polymorphic forms of naltrexone

#6 | 2019-05-02

US20190125878A1

Human necessities

POLYMER-BASED SUSTAINED RELEASE DEVICE

#7 | 2019-01-17

US20190015408A1

Human necessities

Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia

#8 | 2018-10-25

US20180303825A1

Human necessities

Polymorphic forms of naltrexone

#9 | 2018-04-26

US20180110773A1

Human necessities

Polymorphic forms of naltrexone

#10 | 2017-07-27

US20170209430A1

Human necessities

Polymorphic forms of naltrexone

#11 | 2017-03-02

US20170056505A1

Human necessities

POLYMER-BASED SUSTAINED RELEASE DEVICE

#12 | 2016-12-15

US20160362415A1

Chemistry; metallurgy

Polymorphic forms of naltrexone

#13 | 2016-05-19

US20160137657A1

Chemistry; metallurgy

Polymorphic forms of naltrexone

#14 | 2016-02-25

US20160051546A1

Human necessities

Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia

#15 | 2015-08-06

US20150218178A1

Chemistry; metallurgy

Polymorphic forms of naltrexone

#16 | 2014-10-09

US20140303200A1

Chemistry; metallurgy

Polymorphic forms of naltrexone

#17 | 2014-03-27

US20140088003A1

Human necessities

Polymer-based sustained release device

#18 | 2014-01-30

US20140031281A1

Human necessities

POLYMER-BASED SUSTAINED RELEASE DEVICE

#19 | 2013-05-23

US20130130977A1

Human necessities

Polymer-based sustained release device

#20 | 2010-06-17

US20100152111A1

Human necessities

Polymer-based sustained release device

#21 | 2010-06-17

US20100152097A1

Human necessities

Polymer-based sustained release device

#22 | 2009-10-01

US20090247463A1

Human necessities

POLYMER-BASED SUSTAINED RELEASE DEVICE

#23 | 2009-02-05

US20090035253A1

Human necessities

Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar

#24 | 2008-10-23

US20080260847A1

Human necessities

Polymer-based sustained release device

#25 | 2008-09-18

US20080227804A1

Human necessities

Polymorphic forms of naltrexone

#26 | 2008-05-29

US20080125351A1

Human necessities

Polymer-based sustained release device

#27 | 2008-05-29

US20080125349A1

Human necessities

Polymer-based sustained release device

#28 | 2008-05-29

US20080125348A1

Human necessities

Polymer-based sustained release device

#29 | 2008-05-22

US20080119569A1

Human necessities

Polymer-based sustained release device

#30 | 2008-03-06

US20080058502A1

Human necessities

Method for preparing microparticles having a selected polymer molecular weight

#31 | 2008-03-06

US20080054220A1

Human necessities

Apparatus and method for preparing microparticles using in-line solvent extraction

#32 | 2008-03-06

US20080053904A1

Human necessities

Apparatus and method for preparing microparticles using in-line solvent extraction

#33 | 2007-11-08

US20070260038A1

Chemistry; metallurgy

Preparation of microparticles having improved flow ability

#34 | 2007-07-24

US10022859

Preparation of microparticles having improved flowability

#35 | 2007-07-19

US20070166352A1

Human necessities

Polymer-based sustained release device

#36 | 2006-05-25

US20060110423A1

Human necessities

Polymer-based sustained release device

#37 | 2005-12-08

US20050271702A1

Human necessities

Polymer-based sustained release device

#38 | 2005-12-01

US20050266091A1

Human necessities

Method and apparatus for preparing microparticles using in-line solvent extraction

#39 | 2005-09-08

US20050196457A1

Human necessities

Apparatus and method for preparing microparticles

#40 | 2005-09-06

US10729909

Method and apparatus for preparing microparticles using in-line solvent extraction

#41 | 2005-03-01

US10713039

Apparatus and method for preparing microparticles

InventorID:

263476 ⎘